Christopher A. Kroeger, CEO: MapLight Therapeutics MPLT Planned sale · Filed 04/15

Trade details

Type: Planned sale notice
Stock: MapLight Therapeutics MPLT
Person: Christopher A. KroegerCEO
Planned sale date: 26/04/15
Filed: 26/04/15

$562.6K to be sold

MapLight Therapeutics trades, last 26 weeks

What else happened in MapLight Therapeutics around then

Filed or reported within 30 days of the trade day · 03/16~05/15

Christopher A. Kroeger's recent trades

Christopher A. KroegerCEO
Planned saleMapLight Therapeutics
Planned sale
MapLight Therapeutics
MPLT
$5.8M
152,230 sh
$5.8M
Filed 07/15
Traded 07/15
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$3.2M
118,037 sh
$3.2M
Filed 05/18
Traded 05/18
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$5,574
198 sh
$5,574
Filed 05/18
Traded 05/18
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$814.1K
29,624 sh
$814.1K
Filed 05/11
Traded 05/08
Christopher A. KroegerCEO
Sell10b5-1 planMapLight Therapeutics
Sell10b5-1 plan
MapLight Therapeutics
MPLT
$423.6K
14,880 sh
$423.6K
Filed 05/11
Traded 05/07